Related Experiment Videos
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization.
A Saxena1, C J Rorie, D Dimitrova
1Department of Biochemistry and New York University Cancer Institute, New York University School of Medicine, New York, NY 10016, USA.
Oncogene
|June 6, 2006
Summary
Nucleolin protein levels directly impact p53 protein amounts by inhibiting Hdm2, a key regulator. This finding reveals nucleolin
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Nucleolin is involved in rRNA processing and DNA replication inhibition.
- Its role in unstressed cells and p53 regulation is not fully understood.
Purpose of the Study:
- To investigate the effect of nucleolin on p53 protein levels in unstressed cells.
- To elucidate the mechanism by which nucleolin influences p53 stability.
- To determine the functional consequences of nucleolin-mediated p53 regulation.
Main Methods:
- Western blotting to assess protein levels (nucleolin, p53, Hdm2, p21).
- Immunoprecipitation assays to study protein-protein interactions (nucleolin-Hdm2).
- Ubiquitination assays to measure p53 and Hdm2 ubiquitination.
- Cell proliferation and apoptosis assays.
Main Results:
- Nucleolin levels directly correlate with p53 protein levels in unstressed cells.
- Nucleolin binds to Hdm2, inhibiting both p53 and Hdm2 ubiquitination.
- Nucleolin reduces Hdm2 protein levels through mechanisms beyond inhibiting ligase activity.
- Increased nucleolin leads to elevated p21(cip1/waf1) expression, reduced proliferation, and increased apoptosis.
Conclusions:
- Nucleolin acts as a regulator of p53 stability by inhibiting Hdm2.
- Nucleolin shares functional similarities with the tumor suppressor ARF.
- Nucleolin may function as a tumor suppressor by upregulating p53 in response to hyperproliferative signals.